COVID-19 among patients with multiple sclerosis: a systematic review

M Barzegar, O Mirmosayyeb… - Neurology …, 2021 - AAN Enterprises
Objective We systematically reviewed the literature on COVID-19 in patients with multiple
sclerosis (MS). Methods We searched PubMed, Scopus, EMBASE, CINAHL, Web of …

Multiple sclerosis disease-modifying therapy and the COVID-19 pandemic: implications on the risk of infection and future vaccination

C Zheng, I Kar, CK Chen, C Sau, S Woodson, A Serra… - CNS drugs, 2020 - Springer
Abstract The coronavirus 2019 (COVID-19) pandemic is expected to linger. Decisions
regarding initiation or continuation of disease-modifying therapy for multiple sclerosis have …

Emerging COVID-19 neurological manifestations: present outlook and potential neurological challenges in COVID-19 pandemic

S Dewanjee, J Vallamkondu, RS Kalra… - Molecular …, 2021 - Springer
The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …

COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: a systematic review

M Sharifian-Dorche, MA Sahraian, G Fadda… - Multiple sclerosis and …, 2021 - Elsevier
Abstract Introduction The Coronavirus disease-19 (COVID-19) pandemic continues to
expand across the world. This pandemic has had a significant impact on patients with …

Telehealth-based services during the COVID-19 pandemic: a systematic review of features and challenges

F Khoshrounejad, M Hamednia, A Mehrjerd… - Frontiers in public …, 2021 - frontiersin.org
Background: As an ever-growing popular service, telehealth catered for better access to
high-quality healthcare services. It is more valuable and cost-effective, particularly in the …

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis

AN Moghadasi, O Mirmosayyeb, M Barzegar… - Neurological …, 2021 - Springer
Background The prevalence of COVID-19 is different in studies conducted in different
countries. The aim of this systematic review and meta-analysis is to estimate the pooled …

Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder

S Liu, J Han, EL Puyal, S Kontaxis, S Sun, P Locatelli… - Pattern recognition, 2022 - Elsevier
This study proposes a contrastive convolutional auto-encoder (contrastive CAE), a
combined architecture of an auto-encoder and contrastive loss, to identify individuals with …

Multiple sclerosis, disease-modifying therapies and COVID-19: a systematic review on immune response and vaccination recommendations

V Cabreira, P Abreu, R Soares-dos-Reis, J Guimarães… - Vaccines, 2021 - mdpi.com
Understanding the risks of COVID-19 in patients with Multiple Sclerosis (MS) receiving
disease-modifying therapies (DMTs) and their immune reactions is vital to analyze vaccine …

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

R Greco, T Alexander, J Burman, N Del Papa… - Bone Marrow …, 2021 - nature.com
Abstract Coronavirus disease-19 (COVID-19), caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), represents one of the biggest challenges of 21st …

Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: preliminary data of an observational study

S Bonizzato, A Ghiggia, F Ferraro, E Galante - Neurological Sciences, 2022 - Springer
Psychological, emotional, and behavioral domains could be altered in COVID-19 patients
and measurement of variables within these domains seems to be mandatory …